Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial Board159
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity144
Differential immune responses behind different celiac disease manifestations89
Cellular stress and macrophage activation76
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells64
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer61
Exploiting antifungal immunity in the clinical context58
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi56
Pyroptosis modulation by bacterial effector proteins51
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity49
Microbial metabolites and immunotherapy: Basic rationale and clinical indications49
Aging of lymphoid stromal architecture impacts immune responses44
Editorial Board44
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)42
Resolving inflammatory links between myocardial infarction and vascular dementia42
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity42
Immunity to pathogenic fungi in the eye40
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease40
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?40
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity38
Pyroptosis: A road to next-generation cancer immunotherapy37
The noncanonical inflammasome-induced pyroptosis and septic shock37
Pyroptosis and the cellular consequences of gasdermin pores36
Western diet influences on microbiome and carcinogenesis32
Introduction to the special issue: Neutrophils in the tumor microenvironment32
Interplay between the complement system and other immune pathways in the tumor microenvironment32
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment32
Immunity to fungi: Editorial overview31
Introduction to the Special Issue: Nanoparticles and immune responses30
Neuroimmune interactions between itch neurons and skin microbes29
Cellular and molecular diversity in spondyloarthritis28
The paradox of aging: Aging-related shifts in T cell function and metabolism28
Specialized pro-resolving mediators as modulators of immune responses26
The evolving biology of cross-presentation26
Adaptive NK cell response to human cytomegalovirus: Facts and open issues26
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets26
TREM2: A new player in the tumor microenvironment25
Recent developments in C3-targeted complement therapeutics25
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases25
Antigen discovery for the development of cancer immunotherapy24
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy24
The dual role of neutrophils in cancer24
Thymus aging and immune reconstitution, progresses and challenges23
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Sialic acid and Siglec receptors in tumor immunity and immunotherapy22
T cell control of SARS-CoV-2: When, which, and where?21
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
Targeting the tissue-complosome for curbing inflammatory disease20
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
T cell fate decisions during memory cell generation with aging19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity19
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders19
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
Cellular and molecular heterogeneity in systemic lupus erythematosus18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
Publisher's note: Welcome Prof. Guido Kroemer18
Editorial Board18
The complement system in clinical oncology: Applications, limitations and challenges18
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis17
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy17
The glycoimmune landscape in health and disease17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice17
Proteostasis in T cell aging17
Promotion of trained innate immunity by nanoparticles16
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease16
Natural killer cell responses to human oncogenic γ-herpesvirus infections16
Identification of T cell antigens in the 21st century, as difficult as ever16
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review15
Emerging opportunities for C3 inhibition in the eye15
Epigenetic and transcriptional control of gasdermins15
Global aspects of celiac disease and food allergy15
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions15
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging14
Human thymus in health and disease: Recent advances in diagnosis and biology14
The multisensory regulation of unconventional T cell homeostasis14
Harnessing complement biomarkers for precision cancer care14
The gut-enthesis axis and the pathogenesis of Spondyloarthritis13
Impact of cancer cell-intrinsic features on neutrophil behavior13
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics13
A major mechanism for immunomodulation: Dietary fibres and acid metabolites13
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches13
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]13
Unconventional protein secretion by gasdermin pores13
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation13
Nanoparticles for generating antigen-specific T cells for immunotherapy12
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases12
Siglecs as modulators of macrophage phenotype and function12
The role of ILC subsets in cancer12
Systems analysis of innate and adaptive immunity in Long COVID12
Durability of immune responses to SARS-CoV-2 infection and vaccination12
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC12
Microbial gasdermins: More than a billion years of pyroptotic-like cell death12
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond12
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data11
Integrating immunopeptidome analysis for the design and development of cancer vaccines11
Reparative inflammation in multiple sclerosis11
Pyroptosis-induced inflammation and tissue damage11
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease11
Complement regulation in tumor immune evasion10
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas10
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond10
Galectins and Host–Pathogen Interactions: The roles in viral infections10
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation10
Editorial Board10
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies10
Nanoalum adjuvanted vaccines: small details make a big difference10
Polyvalent design in the cGAS-STING pathway9
The gut-brain vascular axis in neuroinflammation9
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function9
Regulatory T cells in allergic inflammation9
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions9
Publisher’s Note: A change in leadership9
Neutrophil metabolism in the cancer context9
Systems analysis of human innate immunity in COVID-199
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences9
0.039264917373657